Bioxytran, Inc.
BIXT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,460 | $20,134 | $55,267 | $42,501 |
| - Cash | $5 | $26 | $295 | $72 |
| + Debt | $1,094 | $1,925 | $2,165 | $2,122 |
| Enterprise Value | $13,549 | $22,033 | $57,137 | $44,551 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$8 | -$8 | -$4 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,223 | -$3,820 | -$2,134 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$2,367 | -$4,280 | -$2,464 | -$4,345 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.017 | -0.032 | -0.021 | -0.041 |
| % Growth | 46.4% | -49.1% | 47.7% | – |
| Operating Cash Flow | -$56 | -$775 | -$1,806 | -$1,697 |
| Capital Expenditures | -$28 | -$44 | -$32 | -$37 |
| Free Cash Flow | -$84 | -$820 | -$1,838 | -$1,734 |